Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Merck & Co. and the Wellcome Trust have created a research and development joint venture focused on affordable vaccines for poor countries. The partners will invest about $130 million over the next seven years to support a staff of 60 researchers. They say the venture marks the first time a drug company and a research charity have formed such an equally funded and separate entity. It will be based in India and called MSD Wellcome Trust Hilleman Laboratories, after pioneering vaccine scientist Maurice R. Hilleman.
This article has been sent to the following recipient: